我国院内获得性肺炎诊治现状  

The Present Status of Diagnosis and Treatment of Hospital-acquired Pneumonia in Our Country

作　　者：金咏絮[1] 林其昌[1] 黄志华[1] 陈公平[1] 林晓[1] 

机构地区：[1]福建医科大学附属第一医院呼吸内科,福州350005

出　　处：《医学综述》2009年第17期2625-2627,共3页Medical Recapitulate

摘　　要：院内获得性肺炎是常见的院内获得性感染,在我国医院感染类型中居首位,其发病率和病死率均高,住院时间长,增加医疗费用,而细菌耐药性的不断增加使治疗困难。因此在临床上有必要尽快明确诊断,根据院内获得性肺炎病原谱的流行病学和临床资料估计可能的病原菌,制订经验性的初始抗菌治疗方案,以提高治疗成功率,降低病死率;同时加强预防HAP发生的措施以降低其发病率。Hospital-acquired pneumonia（HAP） is a frequent categories of the hospital-acquired infections and is the first place in China. The incidence and fatality rate of HAP is high. HAP prolonged hospitalization time and raised medical cost. The increasing bacterial resistance is making difficult to treat HAP. To improve successful rate for treatment and decrease the fatality rate, it is necessary to make final diagnosis as soon as possible, and prepare therapeutic schemes according to epidemiology and clinical data of HAP. At the same time, it must strengthen the preventive intervention to reduce the incidence of HAP.

关 键 词：院内获得性肺炎 诊断 病原学 耐药性 初始治疗 

分 类 号：R563.1[医药卫生—呼吸系统]